Get started
Vor Biopharma Inc.Vor Biopharma Inc.Vor Biopharma Inc.

Vor Biopharma Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

VOR chart

Key stats

Market capitalization
‪122.79 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.75USD
Net income
‪−117.86 M‬USD
Revenue
—
Shares float
‪59.03 M‬
Beta (1Y)
0.58

About Vor Biopharma Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Bob Ang
Website
vorbiopharma.com
Headquarters
Cambridge
Employees (FY)
168
Founded
2015
ISIN
US9290331084
FIGI
BBG00NBJRDT6
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VOR is 1.80 USD — it has decreased by 5.26% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Vor Biopharma Inc. stocks are traded under the ticker VOR.
Vor Biopharma Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Vor Biopharma Inc. has a max estimate of 22.00 USD and a min estimate of 10.00 USD.
VOR earnings for the last quarter are −0.49 USD whereas the estimation was −0.47 USD which accounts for −4.75% surprise. Estimated earnings for the next quarter are −0.50 USD. See more details about Vor Biopharma Inc. earnings.
Yes, you can track Vor Biopharma Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, VOR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vor Biopharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
VOR reached its all-time high on Feb 5, 2021 with the price of 63.62 USD, and its all-time low was 1.62 USD and was reached on Nov 21, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 168.00 employees. See our rating of the largest employees — is Vor Biopharma Inc. on this list?